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HIV Antibody

Performance and
Counseling issues

Testing:

Michael Gross, Ph.D.

This article assesses the performance of currently used tests for exposure to human immunodeficiency virus (HIV), the infectious agent associated with acquired immunodefi-

ciency syndrome (AIDS); suggests, in view of that information, guidelines for counseling

people seeking

HIV antibody testing; and evaluates the claim that because antibody test

results will effect

behavior change

groups should be

tested.

in those

who are infected,

all

members of high-risk

HIV testing is likely to yield a high proportion offalse-positive results in low-risk popuand infants born to infected mothers. A negative result may not establish freedom

lations

from

infection in high-risk groups or the offspring

relate these generalizations to

a

of infected mothers. Counseling should

and expectations from testing. In
and present, counseling should provide both

client 's motivation for

evaluating a client's risk of exposure, past

information about and reinforcement for behavioral risk reduction.

The assertion that members of high-risk groups ought to learn their antibody status is
test performance and even more serious questions

questioned in view of concerns about

about the psychological impact of test results

— both short- and long-term — on people

's

adaptation to protective sex and modification of drug use patterns.

—

November 1983
not long after scientists had concluded that AIDS was caused by a
Intransmissible
agent and months before
associated with
the disease

new

virus

was

a

definitively

— the New York Academy of Medicine published a comprehensive summary of
more than six hundred pages,
AIDS, just three index entries on blood screening refer
measure the efficacy of requesting that prospective

the state of knowledge about the syndrome. In the book's

containing dozens of papers about
to

two short papers attempting to

donors

who are at risk defer themselves.

In current

AIDS compendia,

in contrast, tech-

niques, applications, and interpretations of testing occupy whole chapters.

From a technical interest — how best to screen donations of blood and tissue for the
AIDS — testing has evolved into a major area of biomedical re-

agent associated with

search and an even larger preoccupation, sometimes a battleground, of public policy.

who are HIV-antibody-positive for the MassachuDepartment of Public Health. He also serves as a Support Service (hospice) volunteer with the AIDS Action
Committee of Massachusetts in Boston.

Dr. Michael Gross coordinates support services for persons
setts

,
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Should some or

all citizens

be subjected

purposes of insurance underwriting?

to

mandatory testing?

Is testing a

Is testing

appropriate for

productive adjunct to risk-reduction

education and counseling efforts? Are there any occupations for which screening
sary to prevent transmission in the workplace?

Are

is

neces-

there valid reasons for testing institu-

tionalized populations?

Test

Methods and Performance

An important consideration in determining valid uses of testing is the performance of
currently available methods. This section, therefore, examines the methods, accuracy, and
efficacy of current procedures and the possible meanings of test results.

The next

section

considers the implications of that information in an individual's decision about whether to

HIV testing, and in relation to his or her adherence to risk-reduction guidelines.
Some of the patterns of response by individuals to their test results are then described as a

elect for

context for a discussion in the following section of principles that ought to underly the

adoption of testing programs.

Is

1

There a Test for AIDS?

The

so-called

AIDS test does

not diagnose AIDS.

An AIDS diagnosis requires actual

illness, typically infections or cancers that indicate severe

immune system damage. Even

in the presence of such indicators (opportunistic infections like

pneumonia or toxoplasmosis and cancers such

as Kaposi's

Pneumocystis carinii

sarcoma or non-Hodgkins

lymphoma), other possible causes of immune suppression must first be ruled out, including the use of immune suppressive or steroidal drugs or primary cancers that are themselves

immune

suppressive.

Direct evidence for

2

HIV infection would result from detecting the virus itself. Such

methods, however, are used mainly for purposes of laboratory investigation. 3 Detection of

an immune response to the virus, in the form of antibody to the virus,

is

the

most widely

used form of testing for such purposes as blood screening. But the mere presence of anti-

body

to

HIV does not establish an AIDS diagnosis,

nor does

it

foretell

with certainty the

onset of HIV-related illness in the future; moreover, early detection of HIV does not lead
to prevention of

subsequent symptoms. 4

Why Use Antibody

Tests?

In general, the presence of antibody

is

a

more

consistent indicator of present or past infec-

tion than the presence of the disease-causing pathogen itself.
after the causative agent of an infection has

Antibody will remain long

been cleared from the body. Before much

natural history of HIV infection, it seemed possible that, like
HIV might be eliminated by some individuals' immune response.

became known about the

many

other viruses,

Antibody would then be the only trace of past infection or of ongoing infection with undetectably low levels of virus.

It

now seems

that

most or

all

never successfully eliminate the virus altogether. But in

individuals infected with

its

latent state, the virus

HIV

would be

undetectable by antigen tests and possibly difficult to recover by viral isolation methods.

Therefore, an antibody test
is

practical to use

is

the

on a large scale

most consistent index of HIV infection

available

which

for screening purposes.

Why Use the ELISA Technique?
The most widely used screening method, employing an enzyme-linked immunosorbent

190

assay

(ELISA or EIA),

is

relatively inexpensive (typically, less than

$5 per

test for the cost

of reagents and equipment), highly reproducible, and technologically adapted for processing large batches of samples with efficient, automated laboratory apparatus. In contrast,

tions.

other procedures (for example, viral isolation, Western blot) have technical limita-

They usually depend on the competence, consistency, and particular recipes em-

ployed in a given laboratory 5 and are correspondingly more expensive. They

may

entail

procedures that require special handling (for example, the radioactive reagents used in

DNA probe studies and radioimmune precipitation). They also may be more difficult to
interpret: for instance, both viral isolation

in

and antigen

tests frequently fail to detect virus

samples from truly infected individuals. 6

What Are Current Procedures for Testing?
The protocol used by the Massachusetts Department of Public Health in its testing and
counseling programs, and by the American Red Cross New England Region Blood Service screening program described here, is typical of testing programs across the country
and

internationally.

7

Evaluation of a sample begins with an

ELISA test.

If the reactivity of the

below a predetermined cutoff value standardized for the particular
result is judged negative, that

the observed reactivity

is

is,

no antibody detected.
registers

sample

falls

being used, the

No further testing is undertaken.

above the cutoff value, the same sample

ELISA procedure. When reactivity

test kit

is

If

tested again using the

below the cutoff value on repeat

testing

not an unusual occurrence for samples from low-risk individuals — the sample

—

is inter-

preted as negative.
If the repeat

ELISA test is

also reactive or borderline, the sample

is

subjected to a

specific procedure that ordinarily has the capability to distinguish antibody to

antibody to something

else.

more

HIV from

The immunoblot, or Western blot, can show whether the

ELISA binds to known classes of viral protein. The distinctive banding pattern that appears when the HIV antibody is present confirms a positive ELISA
result. The lack of such a pattern indicates that antibody detected by ELISA was probably
antibody detected by

elicited

If the

HIV which happens spuriously to cross-react with biowas not eliminated when the test kit was prepared.

by some agent other than

logical material that

immunoblot pattern

very faintly perceptible,

still

is

ambiguous, for instance,

another procedure

if

the observed bands are only

may be employed:

the immunofluores-

cence assay. 8 Cells known to be infected with HIV, along with uninfected (control)
are exposed to a serum sample and appropriate reagents. Infected cells will

coated with a fluorescent dye

if

the

serum sample being

tested contains

while uninfected control cells will show no label. Such a result
neither infected nor uninfected cells

become

is

labeled, the sample

antibody. If both infected and uninfected cells

become

cells,

become

HIV antibody,

considered positive. If
is

labeled, the

considered free of HIV

meaning

is

ambiguous,

and the outcome described as "indeterminate." 9

How Accurate Are Antibody Test Results ?
We do not know definitively. ELISA test kits from commercial manufacturers score difon tests meant to standardize their performance. In 1986, five products ranged
from 98.3 to 100 percent in sensitivity, which measures a test's ability to detect infection
when it is present. They ranged from 99.2 to 99.8 percent in specificity, which indicates
ferently

how well a test discriminates true infection from absence of infection. These small percentage changes make a big difference in the proportion of false positives, as discussed
10
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below.

The most

Making comparisons is difficult,
were standardized using different test samples, and
batch, even from the same manufacturer. In a study of

sensitive tests are the least specific.

because each manufacturer's

tests

performance varies from batch

ELISA performance in

five

to

hundred laboratories,

11

thirty-five of approximately seven

thousand positive samples were labeled negative. The laboratories,

were voluntarily participating

in these proficiency studies,

it

should be noted,

and extra care may well have

been taken, since the study samples were so labeled. 12
Western blot

commercial

tests are

test

even more difficult to standardize or compare, because only one

has been licensed. Most laboratories that perform Western blot testing

use reagents they prepare with their

own procedures, and they

define the standards to be

used in judging whether results for a sample are categorized as positive, indeterminate, or
negative.
testing

13

Ten of nineteen laboratories seeking U.S.

were rejected because they

Army contracts for Western blot

failed a test panel at least once.

14

Using panels of am-

biguous samples, the College of American Physicians found 12 to 15 percent of laboratories labeling

two of three reactive samples indeterminate by Western

The comparative performance of immunofluorescence assays
matory procedure

—

is

blot.

— another form of confir-

even less well studied than that of Western blot

Although specimens used

in laboratory studies to standardize the

tests.

performance of HIV

may be abused. No
15

tests receive

optimal treatment, in the real world samples

studies have

been published which examine how much mistreatment of samples

sible before antibody testing

more likely

to

may lead to

even though he or she

test

is

is

permis-

inaccurate results, or whether error would be

be in the direction of false positives or

Are There Many False Positives?
A "false positive" means that someone

systematic

tests positive

false negatives.

or shows reactivity on an antibody

not really infected. Even with a very low rate of false-positive

population of low-risk individuals a large proportion of those few results

test results, in a

which are positive

will falsely label as infected

ual positive results are likely to remain positive

ously cross-reacting with HIV,

it is

someone who is free of HIV. 16 These residon subsequent tests. If antibody is spuri17

not likely to disappear spontaneously. Furthermore,

other confirmatory tests are not likely to clarify the situation. Neither viral isolation nor
antigen tests are ultimate arbiters. Failure to detect virus during viral isolation
to very

sources of failure of that very exacting procedure. Failure to detect antigen

from a

may be due

low levels of virus, rapid death of cells harvested for culture purposes, or other
latent infection in

be detected by antigen
If I Test Positive,

which

HIV is not actively

may

result

replicating, since latent virus

may

not

tests.

What Are

the Chances I

Am Truly

Infected?

The

likelihood that a positive result truly indicates infection

level of risk

and

to the accuracy of the test or, customarily,

lower the risk, the more likely
the

more likely

it is

it is

is

related both to the person's

combination of tests used. The

that a positive result is misleading; the greater the risk,

that a positive result is a true indicator.

For instance, a female

who

and who has tested positive has only a one in seven
chance of truly being infected even when the combined accuracy of ELISA and confirmatory test is as high as 99.95 percent. If the combined accuracy of the test drops to 99.50
meets blood-donor

eligibility criteria

percent, then the likelihood of true infection
active gay

man in Los Angeles, New

is 1

out of 50.

18

Conversely, for a sexually

York, or San Francisco, or an intravenous (IV) drug

192

user in Greater

New York, chances are better than 99 out of TOO that a positive test result
HIV infection.

accurately indicates

These data make sense
tions
that

if

we consider a simple example of two hypothetical popula-

— one low-risk, one high-risk — of

roughly

1

of

1 ,000

1

,000 people each.

A variety of studies suggest

members of the "general population"

tested

randomly

in such

procedures as military screening or studies of serum samples from routine hospital admissions will be found positive. 19
tion rates) as Pittsburgh

Gay men

in such second-tier cities (with regard to infec-

and Chicago have an infection rate of about 300 per

pose a false-positive rate of 0.

1

percent, or

1

In the first case, the chances of obtaining a true and a false-positive
(1/1 ,000). Put another way, the chance that a positive
is

is

,000. Sup-

outcome are equal

a valid predictor of infection

test is

50:50. 20 In the second example, the likelihood of true infection

positive

1

per 1,000, applied to each such group.

300 times greater than the likelihood of a positive

when a sample tests

result arising

from test error.

In other words, in a high-risk population, the predictive value of such a test

is

much

greater than in a low- or no-risk population.

How Long Does It Take for Detectable Antibody to Form
After Exposure ?

The U.S. Public Health Service implies that when exposure leads to infection, three
months is a sufficiently long period for antibodies to develop to detectable levels. 21 But it
is not that simple, and the question is difficult to study. Estimates using animal models or

may be invalid. 22
Definitive information comes from the very few known cases

immune responses

of humans to other viruses

of seroconversion after a

needle-stick accident or a blood transfusion. But these cases, involving direct inoculation

of a substantial quantity of blood,

more

than the

may

occasion a different rate of antibody development

typical routes of viral exposure through sexual contact or

which injected blood droplets are highly

diluted). Also, the

affected if IV use itself or concomitant infections have

immune

IV drug use

speed of response

compromised

(in

may be

the individual's

system.

Published literature documents a few dozen instances of seroconversion within a few

months

after apparent sexual

exposure in gay men. 23 But other examples 24 show latency

periods prior to seroconversion

among gay men of twenty -three, 25 thirty-four, 26 and thirty-

27

six months. Some studies of IV drug users show intervals of nine, fourteen, and eighteen
months between apparent exposure and the development of detectable antibodies. 28 None
of these studies bears on the likely interval for seroconversion in low-risk or very low dose

— for example, the
— may affect their sensitivity.
Finally, viral infection and antibody response within the central nervous system —
detectable by studying cerebrospinal fluid — may not be apparent from studies of serum
exposures. 29 Also, the design and manufacture of particular test kits

amount, species, and source of HIV protein selected

30

antibody. 31 However, such a compartmentalization of infection and antibody response

is

believed to occur only rarely.

Are There Many False Negatives?

We do not know.

For instance, ELISA-negative sera are not routinely screened by other

procedures such as the Western blot, 32 even though when such studies are done they reveal
a rate of false negatives in the neighborhood of

lems

in the consistency of test

establishing

1

percent or higher, 33 owing solely to prob-

performance. The value of a single negative

freedom from infection with

test result in

HIV among people with a history of high-risk
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behavior

is

questionable, since the sensitivity of the

risk individuals.

ELISA test is based on

studies of low-

34

In various situations, even the

most

sensitive test

is

ineffective,

because the subject

being studied, although infected, does not or cannot produce detectable antibody.
at all unusual, for instance, to find false-negative results in

patients.

eral gay

35

In one study of "high-risk" gay

It is

not

symptomatic HIV-infected

men 36 (more likely

to be infected than the genmale population), four of the ninety-six patients studied harbored virus despite

persistent negative results

high-risk gay
antibody.

38

infection,

39

men were

Because

on antibody

tests.

37

In another research report, two of sixty-six

found to harbor virus even though their serum did not reveal

viral isolation procedures

and antigen

tests

do not always identify true

these results may, if anything, underestimate the rate of false negatives. In

men were negative by ELISA, but their
was detected by Western blot, which would not ordinarily be performed on

another series, 8 percent of healthy infected gay
infection

ELISA-negative specimens. 40 This

statistic is consistent

with theoretical estimates of 7

percent based on current test accuracy and typical infection rates for a city like Boston.

41

An example indicates why negative test results may be problematic. In one 1985 study,
a healthy twenty-four-year-old gay man was evaluated who had had 250 lifetime sexual
partners but fewer than 10 since 1981

with 4 partners, and his

last oral

.

42

He had been receptive during anal intercourse only

or anal exposure to ejaculate had occurred four years

before the study. His only symptoms were swollen glands in his neck and recurrences of
herpes. During the two years prior to the study, he had

of "safer sex" and was clinically healthy.

become

consistent in the practice

A series of antibody test results were negative.

In view of the interval since his period of greatest risk, his adherence to protective sex
guidelines, his current health, and the pattern of repeatedly negative antibody test results,

even very cautious counsel would affirm that very probably he was not infected. However,

upon further study, his serum was found
body was detectable.

to contain evidence of

HIV even though no anti-

What About Testing Newborns and Infants?
False-positive results are likely during the first year or so of life in an uninfected child

born
if

to

an HIV-infected mother. False negatives are not unusual,

the child

at

one

to

two years old,

was infected pre- or perinatally.

first year or more after an infant is born to an infected mother, her HIV
which was transferred across the placenta, may remain detectable in the baby's
43
circulation. There is, during that interval, no routine way to determine whether antibody

During the

antibody,

HIV detected in such a baby's serum derives from passive transfer of maternal antibody
HIV infection by the infant's immune system. Positive
results, in short, may well be misleading.
to

or from an active response to

As the baby's immune system develops and maternal antibody disappears, the child
may fail to mount an antibody response to HIV if he or she has been infected since birth. 44
The baby's immune system may not react to HIV that has been present during its entire
life in the same way as it reacts to a foreign substance; consequently, there may be no
immune response — no HIV antibody — even though the child is infected.
Does Presence of Antibody Prove Infectiousness?
Once infected, an individual probably remains infected. But an infected individual may
not be producing enough virus at all times to be able to transmit it to others. Since there

194

is

.

no way

to

know when one

reduction techniques

is

may have been exposed but
Attempts to isolate

when one is not, consistent use of riskwho are HIV-positive and for anyone else who
who does not know his or her antibody status.

is

highly infectious and

essential for people

HIV from blood of antibody-positive individuals

percent of the time. 45 Because viral isolation
that virus is present in

any individual

is

who shows HIV

antibody reactivity, even though

On the other hand,

virus

may

tests,

which show the presence of active virus or viral fragments

tivity.

not be recoverable from a particular specimen.

may be positive in only

tested,

succeed about 75

a difficult procedure, this statistic suggests

a small fraction of individuals

in the

antigen

specimen being

who display antibody

reac-

46

Another indirect source of data is epidemiological: Do individuals with positive antibody tests infect steady sexual partners when they do not follow protective sex guidelines?
They do, sometimes after only a single exposure. On the other hand, about half of the
steady male partners of infected men may not be infected even though the uninfected
partner may have been receptive during anal intercourse with the infected partner on
hundreds of occasions. 47 The same pattern occurs in heterosexual partners, with considerable variance

from study

to study.

48

In a recent study of heterosexual partners of people

unknowingly infected by blood transfusions, 92 percent of male and 82 percent of female

— with an average, respectively, of 180 and 156 unprotected sexual con— escaped infection. A pattern of steadily increasing risk to the uninfected partner

sexual partners
tacts
is

49

suggested by research on the female partners of hemophiliacs (70 to 90 percent of

whom are believed to be infected as a result of having received contaminated blood product concentrates prior to the introduction of screening programs and heat-treatment processes). Studies of these

women suggest that the likelihood of infection with HIV during

unprotected sexual contact increases with the length of time the infected individual has
carried the virus. 50 There are two possible explanations.
the chances
sion

is

become

As more contacts

greater that whatever combination of factors

present. Or, as time passes, people

is

occur, perhaps

required for transmis-

who carry HIV may become more infectious,

perhaps because their health deteriorates to the extent that they begin to produce larger
quantities of virus than their

immune system can inactivate.

Counseling Issues
Counseling individuals seeking
jectives: 51 (1) individualized

HIV antibody testing can accomplish two important ob-

assessment of risk and delivery of tailored, specific, focused

risk-reduction information; (2) assurance of fully informed consent prior to testing. In-

formed consent implies an assessment of whether the test can address the client's motives
for testing as well as an evaluation of whether the individual feels capable of managing the
test

outcome, whatever

it is.

The question of motivation forms

the starting point for the

following outline of issues that ideally should be reviewed in counseling individuals seeking antibody testing.

1

Why is the individual seeking testing now? What triggered the decision to
have the

2.

test

performed?

How accurate is the individual's understanding of the meaning of the test
in relation to his or her concerns?
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3.

How will test results be used? What will be the behavioral and emotional
outcomes?

4.

Is there a clear

understanding of AIDS risk-reduction guidelines?

Why Seek Testing Now?
Much can be learned by finding out not only why an individual has concluded that testing
is

worthwhile, but, more specifically, what immediate concern prompted the decision.

Responses
life,

to that question

and ways

in

may

reveal specifically relevant circumstances in the person's

which the person might use

Some typical triggering motives
• Coercion or insistence

test results

both profitably and harmfully.

include the following:

from a partner that one be

tested. (Is the partner also

seeking testing? Are there issues of guilt, responsibility, power, or moral
superiority underlying this pressure?
persist in seeking

•

it

Would the person seeking

the test

without such pressure?)

Concern about symptoms. (Has the individual consulted a physician? Can

some concerns be discounted

as unrelated to

HIV?

Will negative results

cause the condition to remain untreated? Will a positive

test result lead to

inappropriate self-diagnosis, failure to seek medical attention, or suicide?)

•

who has
who has received a diagnosis of AIDS or AIDS-related
complex (ARC). (How does this new information change anything if the
Recent notification that one has been exposed from a past partner

tested positive or

individual already follows risk-reduction guidelines? If the motivation for
testing is to allay anxiety that has suddenly escalated, will a negative result
Is testing motivated by the wish
on the part of the infected contact?)

accomplish that?
allay guilt

•

that a negative result will

Recent sexual assault, after which the individual wants to establish a "baseline" antibody status, showing that as of the time of the assault, she or he

was not infected; or a past assault, as a result of which the individual wants
to be sure she or he was not infected by the attacker. (Does the assault survivor understand that a baseline negative result shortly after the assault

may

not be definitive [since any other possible exposure in the months before
the assault could also account for the development of a positive result in the

months

after the assault]? If the test is to

tacker, has a lawyer

and testimony

be used in prosecuting the

at-

been consulted for advice about the kind of evidence

be required to pursue such redress? Will the testing
impede the process of counseling and recovery in the
weeks and months following the assault? Is the testing procedure timed in
such a way that the individual will have a strong support system should the

procedure

that will

itself

result prove positive?

How will test results affect the individual's motiva-

tion to practice safer sex?) 52

• Pressure

from a parent or a guardian. (Does the individual's behavioral

history agree with the perception of those

196

who are

applying pressure for

testing? Is the individual being tested able to distinguish his or her
interests

•

from the demands of those attempting

to pressure

A specific news item or media report about AIDS.

(Does the individual

have an accurate understanding of the information and
instance, reports speculating about unusual or

sion need to be labeled as such.]

Are

own best

him or her?)

its

context? [For

unproven modes of transmis-

there genuine risks that the individual

has not recognized which should lead him or her to adopt risk-reduction
guidelines?)

Does the Individual Understand the Meaning of the Test?
Prior to the advent of AIDS, the technical content involved in counseling

— even in com— was relatively

plex decisions regarding prenatal diagnostic procedures and outcomes

straightforward and unchanging, so that attention could be devoted to the ethical and psy-

AIDS, the relevant technical information is not only
complex and difficult, but also incomplete on many key points, and rapidly evolving. At a
minimum, anyone contemplating HIV testing needs to understand the following:
chological issues involved. With

•

A positive test result does not mean that the individual has AIDS or necessarily will develop

•

By

itself,

AIDS.

a positive test result in an individual with medical

symptoms does

not explain the cause of these symptoms.

•

A positive test result means that the individual should consider him- or
herself able to transmit

equipment

(for

HIV to others

sexually,

through sharing injection

any purpose, not just the use of recreational drugs, and

regardless of whether the skin

is

punctured intramuscularly or intrave-

nously); during pregnancy; at delivery; and possibly through breast-feeding.

•

A negative result does not necessarily prove that an individual is free of
infection. Its meaning depends on how long a time has passed since the
most recent possible incidence of exposure; even with the passage of well

over a year since such an incidence, there remain
results, particularly,

•

it is

some

assumed, among individuals

false negative

at

high

risk.

A positive result may not be an accurate indicator of infection in individuals
with very

little

or no identifiable risk of exposure; there

may be no ultimate

standard or measure to which to appeal except monitoring one's medical
status for possible HIV-related

developments, while scrupulously following

risk-reduction guidelines.

What Will Be the Impact of Test Results ?
Not enough information is yet available about the
logical determinants that characterize people

Many,

if

not most, people

who

specific personality profile or psycho-

who respond well or poorly to HIV testing.

seek voluntary testing assume that they will

and are thus hoping for reassurance

that they are not infected.

ered realistically the ways in which a positive result might affect them.

797

test

negative

Often they have not consid-

Many people who

New England Journal of Public Policy

AIDS or
may have

are in ongoing counseling or psychotherapy never mention their concerns about
their interest in

HIV testing to their therapist. And if they do,

encouraged them

to

be tested, secure

anxiety, without ever having

their counselor

would reduce the

in the belief that the test

examined with the

client the possible

result. Certainly, the test is specifically contraindicated

client's

impact of a positive

by a risk of suicide, homicide, or

other sociopathic behavior; risk of abandoning drug treatment; or other probable adverse

outcomes.
In the absence of risk of those specific adverse outcomes,
tain
if

whether the individual's behavior will be any different

he or she

tests negative. If

tion guidelines
is

may be

positive or negative.

If a

important to try to ascer-

he or she

than

tests positive

an individual feels that he or she may be infected, risk-reduc-

appropriate whether or not she or he

Using

inappropriate, since the test

it is

if

test results to

is

make

tested,

is

and whether the

career choices or financial plans

an uncertain predictor of actual

test

may be

illness.

woman or a couple is using the test to help make a decision about becoming preg-

nant or terminating a pregnancy, even with a positive result the best choice

gone conclusion. As with any other application of the
relation to one's history of risk.

certain that her infant will

And even if a mother is truly

become

not a fore-

— that about 50 per— averages statistics from spe-

infected; the prevailing estimate

cent of infants born to infected mothers are also infected
cific studies

is

must be evaluated in
infected, it is by no means

test, results

whose estimates range from about 20 percent to

as high as

80 percent.

women may reasonably choose to bear a child knowing that it may be born
with Down's syndrome, hemophilia, or Tay-Sachs disease or that it may develop Huntington's chorea, so a parent or parents may determine that the risk is acceptable of giving
birth to a child that may or may not be infected and, if infected, may or may not proceed
Finally, just as

to develop

AIDS.

When a principal motive for testing is reduction of anxiety,

the individual

must consider

whether a positive outcome would greatly exacerbate his or her anxiety and whether some
uncertainty actually

is

preferable. For an individual at very low or no risk, a positive

result is unlikely and, should
positive.

it

occur,

may be misleading because it may

well be a false

When the risk of obtaining a false positive is about equal to the risk of actual

infection (for example, for people

who were transfused with one or two units

of blood in a

low-risk area prior to the introduction of routine blood screening in the spring of 1985),
the decision about whether to proceed with testing

is

a difficult judgment to make.

Experience with repeat and chronic test-takers suggests that although people
pect test results to allay anxiety, for

many people they do

(appropriately or not) on the ambiguities inherent in
testing even

may

ex-

Sometimes people seize
a negative result and seek repeat
not.

though no amount of testing will finally dissipate

their anxiety.

who test negative and appear at first to be greatly relieved that they

Some people
may

have been spared

find, with the passage of time, that they are less able to maintain risk-reduction behavior.

They repeatedly put themselves at risk, and chronically reappear for testing as a way to
"monitor" whether they have gotten infected yet.
When people seek testing as a license to abandon risk-reduction precautions, they fail
to recognize that it becomes more and more likely as time goes on that each new partner
will be infected. The need will become progressively greater to adopt safer sex techniques
and to be sure that if drug injection equipment is used it is sterile. Although the test may
allay worries about the past, for

most people the greater challenge looms

in the future:

developing and stabilizing habits that provide continuing protection from the possibility of
infection.

The apparent

clarity of a positive or a negative result

198

may obscure the daunting

but necessary effort to adapt to a changing environment in which safer sex must

become

the norm.

Does the Individual Understand and Follow
Risk-Reduction Guidelines?

Few

situations illustrate better than the

AIDS

epidemic that individuals do not

fit

into

more important than self-designated
identity in evaluating someone's risk of exposure and, more important, in delivering riskreduction information. A gay man who always preferred very safe sex practices may
simple, unitary categories. Actual behaviors are

nevertheless have had an accident or illness that required multiple blood transfusions

before screening was introduced.

Some men with hemophilia are gay, and some gay men

with hemophilia inject recreational drugs and share needles. Loving husbands and devoted fathers

may

sustain long-term partnerships with other

men in a similar situation

without defining themselves as "gay," "homosexual," or even "bisexual." Former intravenous drug users

who have been clean for months or years may continue to have

sex-

ual relationships primarily with other ex-users or current users. Lesbians sometimes want

a gay male friend to father a child.

Some heterosexual women like anal intercourse.

Heavy drinkers who black out may

forget not only

also the gender of their partner.

It

matters

what kind of sex they engaged

in but

when and where risky behavior occurred. For

instance, unprotected heterosexual intercourse with a

man with hemophilia living in Pitts-

burgh may be much more risky than with an IV drug user

in Ottawa.

Risk-reduction recipes sound simple in principle. Needle sterilization seems as easy as
rinsing out a drinking glass, and

assort safe, possibly safe, and unsafe sex acts

lists that

when people nod their heads and say, "I understand," they may be suffering under significant misconceptions, or may be finding themselves unable to talk about how hard it is to put those simple guidelines into practice.
The phrase "exchange of bodily fluids" euphemistically avoids key particulars. Saliva,

appear perfectly straightforward. But

sweat, and tears are far less menacing than blood or semen. "Exchange," which sounds
like a

bank transaction, offers

When the phrase

little

clarification about

"direct blood contact"

is

HIV

lead, because the important blood cells in

blood

cells that

how HIV may

employed to

actually infect.

clarify "exchange,"

infection are white, not red.

HIV attacks may be present at any

site

it

may

mis-

The white

of infection and inflammation, as

well as locations where blood vessels are actually ruptured or penetrated.

AIDS epidemic, "promiscuity" has recurrently been cited as
HIV transmission. But an emphasis on number of partners may belie the

Since the beginning of the
a key factor in

obvious: that a mutually

monogamous, unprotected sexual

relationship with an infected

much riskier than scrupulously safe sex with a multiplicity of strangers. Gay
men in monogamous relationships seem less likely to be consistent about risk-reduction
guidelines than men who have nonsteady partners. 53 For instance, an important reason
why some gay men in San Francisco continued receptive anal intercourse was that they

partner

is

accepted a single-minded public health emphasis on the dangers of promiscuity and

"anonymous partners" and believed
them. 54 But

statistical analysis

that having

fewer sexual partners would protect

suggests that even in 1982 the spread of HIV in that city was

such that a 50 percent reduction in the number of partners per year with no change in
actual sexual practices

would have reduced the likelihood of exposure by only about 10

percent. 55

Not

all

sexual contacts are consensual.

sault, the obstacles to

Even

in less coercive settings than sexual as-

adopting protective sexual practices
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may

not be informational, but
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woman with young children whose sole source of financial support is an
who has multiple sexual partners or a pattern of chronic needle sharing
during IV drug use, or both; a family, religion, and culture that tell this woman that her
fulfillment in life requires that she accede to her partner's demands; a man who obtains
sexual release only after drinking so much that he cannot remember whom he has slept
with or what kinds of sex he had; anyone who agrees that the measure of their love and
devotion or the guarantor of monogamy in a relationship is their willingness to have unprotected sex; a sex worker (someone who is paid for sex) whose client will pay a much
situational: a

abusive husband

higher fee

if

he does not have to use a condom.

What Are the

When People Learn

First Reactions

Their

Test Results?

People usually react to the news of a negative result the way one would expect
considerable relief. Surprisingly often, however,

some respond with

occasionally, with almost a sense of letdown. 56 People
tive display a

— with

indifference, and

who learn that their test was posi-

wider range of immediate responses, including outbursts of strong feeling,

especially sorrow and anger; withdrawal; stoic acceptance; a jumble of questions and

thoughts; and intellectualizing (for example, "It's what

ever

I

have to do to keep from getting sick").

definitive information that
that results

one

from uncertainty.

in the case of persons

I

is

infected

It

I

expected,"

"Now I'll do what-

has been suggested that for some, the

may be calming because it reduces

have observed

this

the anxiety

response on only a few occasions. Even

who appear most genuinely convinced that they have been infected

with HIV, a positive result dashes the optimism and hope that they seem to bring with

them

to the test situation.

Over Time,

How Do People Deal with Being

HIV-Antibody-Positive ?

People

who have tested positive are divided about whether they ever should have had the
test. Those who value it feel that it has been helpful in making decisions about

antibody

matters such as medical care, health maintenance, and financial planning; in setting priorities;

and in helping them

lovers, family,
their

to affirm the relative

and friends. They

commitment to

importance of various relationships with

rarely, if ever, feel that testing has significantly

protective sex

changed

— unless one views a change from consistently safe

sex to abstinence as a significant contributor to public health.

Those who regret having learned

their status experience a

Some persons who have tested positive describe, even years
status,

The resulting anxiety and depression may become self-perpetuating,
when such feelings are interpreted as early signs of neurological damage due

disaster.

particularly

to the progress of an

the

after learning their antibody

— sometimes omnipresent — feelings of foreboding, gloom, and im-

profound

pending

wide range of problems. 57

most guarded

HIV infection.

fear,

In a support group I co-led for seropositive gay men,
which was verbalized only in the tenth week of a twelve-week

program, was the fear of literally losing one's mind
Often there

is

tremendous uncertainty about how

to

HIV infection.

to deal with a

medical situation that

is

news of an experimental treatment one day is juxtaposed
the next with reports of a gloomy prognosis for anyone who is infected. It is easy to collect
a portfolio of tales of insensitive, AIDS-phobic, homophobic, and drug-phobic providers
in medicine, dentistry, mental health, and alternative healing modalities. But even warm,
patient, trusted, sensitive providers have biases about the benefits and risks of specific
constantly changing. Optimistic
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treatments, whether conventional, experimental, or alternative. This diversity of opinion
it imposes a burden that many medical consumers have neither the
temperament to bear. Gaining sufficient knowledge to make responsible
choices may become as consuming as a full-time career, and also may leave the affected
person with an overwhelming and inappropriate sense of responsibility for his or her own

may be healthy,

but

training nor the

medical

fate.

People having difficulty with the knowledge that they tested positive describe struggle

and pain

in their relationships. Friends

sometimes withdraw, perhaps out of irrational fear

own situation. Or they may become oppresThe issue of disclosure may become a preoccupation. Does one tell
family members? Which ones, and when? Must or should one tell one's employer, and, if
so, when? Gay men liken the experience to "coming out," but without the sense of joyous

of exposure or anxieties triggered about their
sively solicitous.

celebration that often accompanies acknowledging and beginning to experience one's

sexual identity.

may become problematic, especially if one's current sexual partner tests
know his or her status. Does one inform any or all past sexual partners or fellow drug users? What about the possible emotional fallout: blame, guilt, sorrow, old wounds reopened? Does one tell a prospective sexual/emotional partner? Can a
relative stranger be trusted with this information after only a first encounter? What about
the pain of rejection if the news is shared only when the relationship has gained in closeRelationships

negative or does not

ness and significance? If the information

scrupulously safe one,

is

conveyed after a sexual encounter, even a

how does that affect trust in the future,

if

the relationship survives

such a disclosure? If one decides to restrict sexual relations only to those
tested positive,

how does one meet them?

If

one chooses

celibacy,

how

who have also

are needs for inter-

personal warmth, intimacy, and physical closeness to be met?

Policies for Testing

Testing

is

now one of the most popular items

in

AIDS budgets. Counting becomes conmuch from emotion as

fused with controlling. 58 The principal reasons for this derive as

from reason. Everyone experiences a sense of urgency

do something, preferably someThe
groups other than those to which

to

thing palpable, quick, easy, universally applicable, and mechanically predictable.

uncharitable perception endures, usually with respect to

authors of pro-testing recommendations belong, that "they" will change behavior only

if

somehow shocked or flogged into it by the distress of a positive test result. 59 The
misconception persists among many policymakers that people who test negative need be
they are

less

worried about transmission that those

who test positive.

Testing also has the effect,

desirable to some, of diverting educational dollars into fiscal support of laboratories and

A mechanical procedure like drawing blood samples
and running them through a laboratory procedure seems somehow more hard-hitting,
objective, and productive than education, which seems soft
just a cozy little chat about
collection of epidemiological data.

—

sex.

Does Knowing One *s Antibody Status Lead to Risk
Reduction?

Long-term reactions

to learning one's antibody status

mostly anecdotal. This

is

in maintaining safer sex

remain poorly documented and

important, because longitudinal studies of the factors important

do not agree with cross-sectional
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studies. 60 Relatively

few people
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HIV antibody

have known their

status for

more than a year or two. Many of those who

have been studied are in individual therapy or support groups or research studies,

which
tions

select subjects

who are

in certain

ways nonrepresentative. 61 Some

of

all

clinical interven-

may select specifically for people experiencing difficulty managing this knowledge.
may attract those who already are coping very well. Besides knowledge of anti-

Others

body

status, usually all subjects in

such studies are receiving some form of systematic

professional attention, educational interventions, and support as part of the research protocol.

What we do know is not especially encouraging. Some studies of short-term outcomes
do indeed suggest that people who learn they have tested positive reduce risky behavior to
a greater extent than people

who have tested negative. 62

sound — assuming that the negative result

is

This

is

not as reassuring as

since there remains the risk of future exposure. Other findings suggest that those

learn they have tested negative

those

may be less committed to

who do not learn their antibody

status.

suggests that learning one's antibody status

63

is

make

sound research studies

who

Although the U.S. Public Health Service

"an important component of prevention

65

to date suggest that, at least for
status

gay men, other factors besides

weigh more heavily

in the consistent, sustained prac-

Of great importance to these persons is the perception that they

situated in a supportive peer

community

that holds shared values about the

safer sex. Paradoxically, persons with the greatest sense of vulnerability to

as those

will

it

a concerted effort to reduce risk, 64 the most methodologically

knowledge of one's antibody
tice of safer sex.

—

adopting safer behavior than

strategy" for individuals with a history of high-risk behavior, presumably because

motivate them to

may

it

a valid indicator of freedom from infection

who have tested positive — may have the greatest difficulty

are

importance of

AIDS —

in adjusting to

such

and

maintaining safer practices. 66 Individuals already having difficulty with impulse control

— who have not integrated knowledge of risk reduction with behavior — may not

upon learning they are infected with HIV. 67 This is consistent with
the observation that intravenous drug users who are in the early weeks of drug treatment
and who learn they are antibody-positive are more likely to drop out of such programs or
return to injecting drugs, or both, than if they learn they are antibody-negative or do not
learn their antibody status. 68 Anecdotally, people who have been in recovery from drug
addiction for a year or more have remarked to me that they doubt they could have handled
news of a positive antibody status during their first three to six drug-free months.

become more

cautious

Should All Members of "High-Risk" Groups Be Tested?
Antibody screening has been recommended for all members of so-called high-risk groups
and is required of any captive or disenfranchised populations available to the federal and
various state governments, including immigrants seeking to become naturalized citizens;
prisoners; and military, Peace Corps, Vista, and

all

foreign service personnel. In a pio-

neering analysis of HIV antibody screening programs, 69 Bayer et
cal principles

al.

have stipulated ethi-

and have located pragmatic grounds for rejecting mass screening

for

hospital admissions (except perhaps in custodial institutions), marriage, prison, or the

workplace (except perhaps "prostitutes"). 70 Most public health

officials concur, sharing

concerns about the accuracy and efficacy of tests, the relative costs in comparison with
71
other prevention interventions, and legal as well as ethical implications.

But, setting aside three basic principles that they propose

"beneficence," and "justice" — Bayer et

deny that individuals

at

al.

— "respect for persons,"
harm principle," and
know" their antibody sta-

focus on a fourth, "the

high risk should have "the right not to
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They argue

tus.

because "there

for use of the antibody test

is

reason to doubt that advice

alone provides sufficient motivation" for "radical alterations in sexual conduct and in
childbearing plans.

.

.

Given the

.

AIDS and the uncertainty

risks associated with

about

modify high-risk behavior, there is a strong community interest in encouraging voluntary testing." The authors acknowledge, however, that "such information
may be so psychologically devastating that the individual will suffer greatly without any

what

will in fact

benefits to himself or herself or additional benefits to others."
I

believe their position

dichotomy:

we

is

72

flawed for three reasons. First, the argument poses a false

are not forced to choose between advice and testing. Another option must

be made available for anyone

— aware of their antibody status or not —

having difficulty

reducing high-risk behavior or in danger of relapse: sensitive, responsive, creative pro-

grams

that support the process of achieving a satisfying adaptation to the requirements for

sexual risk reduction.
ioral change,

This

is

73

Second,

"information"

why assume that when "advice" does

not effect behav-

— in the form of knowledge of one's antibody status — will?

particularly problematic, for reasons given by Bayer et

al.

:

"There

is

no way

to

discern in advance which of the infected people will modify their behavior without notification and which will not,"

74

nor, I

would add,

is

way

there a

to discern in

advance which

persons, given notification, will modify their behavior in harmful ways.

Third, Bayer et

al. institute

a revealing double standard. For health care providers per-

forming invasive procedures, a risk of HIV transmission exists which
theoretical," for instance, if an accident exposes the

is

more than "only

open wound of a patient to blood from

a health care worker. Health care personnel are advised to take "standard infection control precautions

.

.

.

whether or not they know

are futile for accidents in which blood

their antibody status."

drawn

is

Such precautions

— for example, when a blade slips and

Why not here,

cuts through single or double latex gloves.

75

too,

accord priority to the harm

principle and argue forcibly for submission to voluntary testing by

all

health personnel

who perform invasive procedures? Why suppose that knowledge of one's antibody
is

status

an indispensable motivator for sexual risk reduction but has no bearing on scrupulous-

ness about infection control, no influence on the care taken to avoid accidents, and no
relevance to the desirability of voluntary job reassignment for HIV-infected health personnel performing invasive procedures?

The point here

ers performing invasive procedures have

no

but rather to suggest that there

to conventionally defined high-risk

one

else.

is

not to argue that health care work-

remain uninformed of their antibody

serious inequity in denying "the right not to

status,

know"

is

right to

groups while implicitly extending

it

to every-

76

How Should Testing Programs Be Evaluated?
To the

ethical principles

Bayer

et al.

propose in their analysis of screening programs,

I

suggest adding two criteria for the evaluation of testing proposals: (1) that they are the
least intrusive

way

to

accomplish a necessary goal, and

(2) that they

obey the fundamental

dictum of medicine to do no harm.

As an example of the first principle,
tion can be
ples,

met without testing and

coded by source

(for

the need for epidemiological data

on

rates of infec-

labeling specific individuals as infected. Blind sam-

example, inner-city vs. rural newborn infant blood samples

used in an ingenious study of childbearing

women in Massachusetts77 )

can reveal a great

deal about infection rates in the general population, and voluntary testing programs as

well as noncoerced participation in research studies already have provided
tion, not

much informa-

only about overall rates of infection, but about the dynamics of HIV transmission.
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The second principle encapsulates the problem with widespread use of HIV testing as a
means of effecting behavior change: it is a psychologically invasive procedure of unproven benefit. Although no physically invasive procedure
chemotherapy, surgery, or

—

other medical treatment

—

benefit equals or exceeds
is

is

its

widely adopted without evaluating whether

risk,

HIV testing has not been

sufficiently psychologically intrusive to have

for

some

suicides.

And it is

experimental

anticipated

its

so stringently reviewed. Yet

it

been the immediate precipitating factor

— of uncertain benefit and of unknown risk in

terms of long-term adverse psychological sequelae.

The cautious

evaluation of drugs used to treat patients with

AIDS models

appropriate

care in evaluating unproven treatments. The medical profession weighs seriously the
physical

harm done by

a drug with dangerous side effects, even though

human compas-

sion and the danger of imminent death both dictate the most expansive availability of any

promising therapeutic agent for AIDS. In contrast, advocates of testing programs
cavalierly dismiss psychological morbidity.
tion plan needs to

benefits.

be implemented

78

They may never even mention

for analyzing

that

may

an evalua-

outcomes, and weighing their risks and

79

Drug trials

offer a valid

ventions. Although

paradigm

for considering risky,

Suramin was an effective

more harm than good when employed on

unproven psychological

antiviral agent in the test tube,

it

inter-

apparently

AIDS: carefrom misuse of a drug that appeared
at first to be promising. When Azidothymidine (AZT, or zidovudine, or Retrovir) was
shown in the laboratory to be of apparent benefit in inhibiting the growth of HIV, it was
distributed widely to AIDS patients only after two phases of trials: one to identify whether
a dose existed that the human body could tolerate without irreversible harm, and a second
did

ful, skeptical

to establish

a small sample of people with

evaluation was essential to spare people

whether treatment conferred any benefit. In that second phase, parallel dou-

ble-blind placebo-controlled studies enrolled patients
basis of such studies,

from

specific subgroups.

80

On the

AZT currently is recommended only for persons with AIDS as

diagnosed by a history of Pneumocystis carinii pneumonia and for persons with helper Tcell

counts below a specified threshold. Without sufficient evidence of benefit for other

subgroups,

AZT is not routinely recommended for all people with AIDS, much less all

people infected with HIV.

Compare that caution and

specificity with the blanket

uals in so-called high-risk groups seek voluntary

HIV

recommendation

that all individ-

antibody testing, or with arguments

more widespread mandatory testing (sometimes euphemistically referred to as
We need to know how intravenous drug users react who are not in
treatment, who are in methadone programs, who are now drug-free, who are in Alcoholics Anonymous, Narcotics Anonymous, or other twelve-step recovery or self-help
for even

"required" testing).

programs,

who are breadwinners

community housing, who are
long-term

monogamous

for families,

living alone,

who

still

practicing high-risk sex with various partners,

married bisexual men.

ticing high-risk sex only with long-term

compared to gay men who are

We need to know how test results affect gay men

compared

who

We need to know how gay men in

relationships react to test results,

not,

to

are in shelters for the homeless or in

and so on.

compared with gay men who are pracpartners, compared with gay men

monogamous

routinely are essentially safe in sexual behavior. Hardly any information exists about

the specific psychological profile

— in terms of such factors as locus of control, risk takand so on — of persons

ing, capacity for intimacy, tolerance for ambiguity, self-esteem,
likely to benefit

from testing. And until such research
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is

done,

it is

no more

ethical to

.

prescribe antibody testing for

recommend AZT

all

members of high-risk groups than

for everyone infected with

it

Public health policies that endorse widespread or "routine" testing

who deal

problems already experienced by health educators

may

would have been

may compound the

with AIDS.

A single example

suffice. Mistrust of medical expertise already accounts for unyielding public

about

AIDS

to

HIV.

concern

What will be the effect on public trust and
of testing programs that falsely label half of those who test positive as in-

transmission via casual contact.

public policy

fected carriers of a lethal virus, while erroneously reassuring thousands of infected peo-

ple

who test negative that they have nothing to worry

*#

about?
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of HIV from a tissue
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it
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in
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'

like this before

so they

and they simply don 't know what to make of us,

humor us. PWAs are not seriously consulted on decisions

that affect our lives
to

and our freedoms. PWAs are always

know anything about what the government is doing.
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Glossary

Etiologic agent.

The cause or source of a disease;

in the case of

AIDS, the

infectious virus.

Immunosuppression.

Abnormal or depressed
integrity; especially,

Interferon.

ability to

maintain immunologic

inability to fight infection.

A protein capable of limiting superinfection; produced by
cells

Interleukin.

an

when infected with a virus.

A protein substance produced by white blood cells which
regulates the function of other white cells and intracellular
virus replication.

Seroepidemiology.

The prevalence and distribution of antibodies,
degree and extent of infection of a population.
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